Disruptive reproductive technologies

descriptionPublicationkeyboard_double_arrow_right Article 11 Jan 2017 United States English Publisher:American Association for the Advancement of Science (AAAS)Journal:Science Translational Medicine, volume 9 (issn: 1946-6234, eissn: 1946-6242,

Copyright policy )

Authors: Cohen, Glenn; Daley, George; Adashi, Eli Y.;

doi: 10.1126/scitranslmed.aag2959

pmid: 28077678

Disruptive reproductive technologies

- Summary
- Subjects
- Metrics

Abstract

In vitro gametogenesis raises new possibilities for reproductive and regenerative medicine as well as vexing policy challenges.

Country

United States

Related Organizations

Boston Children's Hospital
United States
Brown University
United States
Harvard University
United States

Keywords

United States Food and Drug Administration, 610, 600, General Medicine, Fertilization in Vitro, Regenerative Medicine, Gametogenesis, United States, Mice, Germ Cells, Reproductive Techniques, Infertility, Animals, Humans, Cell Lineage

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	40
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%